IMMvention Therapeutix, Inc., a Durham early-stage biotechnology company focused on discovering and developing human ...

IMMvention Therapeutix, Inc., an early-stage biotechnology company focused on discovering and developing human therapeutics, today announced a strategic collaboration and license agreement with Novo ...

Indian equity markets ended positively, with the Nifty closing above 23,100 despite intraday volatility. The index rebounded ...

One of the hottest growth areas in the healthcare landscape these days is the obesity drug market because of a class of drugs ...

European stocks jumped to a record high on Wednesday powered by heavyweight technology and healthcare stocks, with markets ...

European stocks extended their recent run of gains on Wednesday, with strong holiday-quarter performance from Adidas pushing ...

The Stoxx Europe 600 hit a record high on Wednesday, in the latest sign of bullish sentiment among global investors. The broad-based European index rose 0.6 per cent to 529.14, led by stocks in the ...

A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...

The pan-European STOXX 600 was up 0.5%, as of 0822 GMT, and trading at its highest level since Sept. 27, 2024. Heavyweight ...

Europe’s Stoxx 600 index hit a record high for the first time since September, as investors grew optimistic that the harshest ...

The team categorized pediatric obesity treatment response, based on changes in body mass index standard deviation score, as ...